Cell Therapeutics, Inc. (CTI) Reschedules Third Quarter 2012 Financial Results to Thursday, November 1, 2012
SEATTLE, Oct. 29, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that due to severe weather on the East Coast of the United States related to Hurricane Sandy, CTI will now be releasing its financial results for the third quarter 2012 on Thursday, November 1, 2012, and will hold the related investor conference call the same day at 8:30 a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific Time. CTI had previously planned to announce its third quarter 2012 financial results on October 30, 2012.
Conference Call Numbers
Thursday, November 1
8:30 a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific Time
1-877-941-2333 (US Participants)
1-480-629-9773 (International)
Call-back numbers for post-listening available at 11:30 a.m. Eastern:
1- 800-406-7325 (US Participants)
1- 303-590-3030 (International)
Passcode: 4572038 #
Live audio webcast at www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.
Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert
Media Contact: | Investors Contact: |
Dan Eramian | Ed Bell |
T: 206.272.4343 | T: 206.272.4345 |
C: 206.854.1200 | |
F: 206.272.4434 | |
SOURCE Cell Therapeutics, Inc.